COMPANY
Origenis is an independent, privately owned
Germany-Switzerland-based company founded in October 2005.
Origenis offers creative services for drug design, synthesis, and
characterisation driven by its patented technology platform
MOREsystem®.
Origenis offers tangible advantages to its customers and partners
through its proprietary, unique, robust, and validated technology
platform, its experienced interdisciplinary team, and its strong
attitude towards success.
Origenis has customized and assembled the finest hardware and lab
equipment on 1000m˛ lab space.
